Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chengxin Deng
Observed names:
C X Deng,
C. Deng,
CHENGXIN DENG,
Cheng-Xin Deng,
Cheng-xin Deng,
ChengXin Deng,
Deng, Chengxin
show all 7
Institutions:
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University
Observed institutions:
Guangdong General Hospital,
Guangdong Academy of Medical Sciences,
Guangdong Provincial People's Hospital,
Southern Medical University,
South China University of Technology
ORCID:
0000-0003-0397-6837
Observed ORCID:
0000-0003-0397-6837
OpenAlex ID:
A5101452446
Mesenchymal stem cell as salvage treatment for refractory chronic GVHD
2010
·
J Y Weng
, X Du
, et al.
·
Bone Marrow Transplantation
·
252
PDF
A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
2018
·
Jianyu Weng
, Peilong Lai
, et al.
·
Journal of Hematology & Oncology
·
121
PDF
The hENT1 and DCK genes underlie the decitabine response in patients with myelodysplastic syndrome
2014
·
Ping Wu
, Suxia Geng
, et al.
·
Leukemia Research
·
37
Co-occurrence of RUNX1 and ASXL1 mutations underlie poor response and outcome for MDS patients treated with HMAs.
2019
·
Ping Wu
, Jianyu Weng
, et al.
·
Europe PMC (PubMed Central)
·
23
Premature exhaustion of mesenchymal stromal cells from myelodysplastic syndrome patients.
2017
·
Yanbin Pang
, Chengxin Deng
, et al.
·
Europe PMC (PubMed Central)
·
17
Analysis of the expression of PHTF1 and related genes in acute lymphoblastic leukemia
2015
·
Xin Huang
, Suxia Geng
, et al.
·
Cancer Cell International
·
16
PDF
Effects of the combination of decitabine and homoharringtonine in SKM-1 and Kg-1a cells
2016
·
Suxia Geng
, Han Yao
, et al.
·
Leukemia Research
·
13
Dynamics of PD-1 expression are associated with treatment efficacy and prognosis in patients with intermediate/high-risk myelodysplastic syndromes under hypomethylating treatment
2022
·
Suxia Geng
, Ruohao Xu
, et al.
·
Frontiers in Immunology
·
12
PDF
Bone marrow mesenchymal stromal cells in chronic myelomonocytic leukaemia: overactivated WNT/β‐catenin signalling by parallel RNA sequencing and dysfunctional phenotypes
2021
·
Ruohao Xu
, Xin Huang
, et al.
·
British Journal of Haematology
·
10
Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single center.
2021
·
Kexin Ai
, Minming Li
, et al.
·
American Journal of Cancer Research
·
8
WT 1 mRNA level reflects disease changes and progression of myelodysplastic syndromes patients with ‘stable disease’
2018
·
Xin Du
, Suxia Geng
, et al.
·
British Journal of Haematology
·
8
The Synergistic Effects of Decitabine Combined with Arsenic Trioxide (ATO) in the Human Myelodysplastic Syndrome Cell Line SKM-1
2016
·
Ping Wu
, Long Liu
, et al.
·
Indian Journal of Hematology and Blood Transfusion
·
8
PDF
Diagnostic and prognostic value of ferroptosis-related genes in patients with Myelodysplastic neoplasms
2023
·
Xiaomei Chen
, Chao Li
, et al.
·
Hematology
·
7
PDF
Hypomethylating agents in the treatment of chronic myelomonocytic leukemia: a meta-analysis and systematic review
2021
·
Ruohao Xu
, Minming Li
, et al.
·
Hematology
·
7
Decitabine With or Without Micro-Transplantation for the Treatment of Intermediate or High-Risk Myelodysplastic Syndrome: A Chinese Single-Center Retrospective Study of 22 Patients
2021
·
MinMing Li
, Chao Li
, et al.
·
Frontiers in Oncology
·
4
PDF
Correction to: A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia
2019
·
Jianyu Weng
, Peilong Lai
, et al.
·
Journal of Hematology & Oncology
·
4
PDF
A retrospective study comparing azacitidine with decitabine in Chinese patients with refractory anemia with excess blast based on two clinical trials in a single center.
2019
·
Ruohao Xu
, Xiaomei Chen
, et al.
·
PubMed
·
4
Role of Toll‐like receptor 4 signaling in cutaneous chronic graft‐versus‐host disease
2015
·
Jianyu Weng
, Peilong Lai
, et al.
·
Clinical Transplantation
·
4
Targeting UGCG sensitizes AML cells to venetoclax through RAB32-mediated endoplasmic reticulum-mitochondria communication
2026
·
Xiaofan Sun
, Yue Li
, et al.
·
Cell Reports
·
3
Outcomes of intermediate or high‐risk CMML patients treated with hypomethylating agents combined with venetoclax: A single center experience
2023
·
Chao Li
, ChengXin Deng
, et al.
·
Clinical and Translational Science
·
3
PDF
[Acute pancreatitis induced by cyclosporine a following allogeneic hematopoietic stem cell transplant].
2009
·
Rong Guo
, Xin DU
, et al.
·
PubMed
·
3
miR-103-3p regulates the differentiation of bone marrow mesenchymal stem cells in myelodysplastic syndrome
2022
·
NINGYU LI
, XIAOFANG CHEN
, et al.
·
Biocell
·
2
PDF
Colon perforation due to cytomegalovirus infection in a patient with idiopathic hypereosinophilic syndrome: a case report
2020
·
Bin Luo
, Chengxin Deng
, et al.
·
BMC Gastroenterology
·
2
PDF
Combination of Cladribine, Cytarabine and Topotecan (CLAT) for Relapsed or Refractory Acute Myeloid Leukemia
2015
·
Xiaomei Chen
, Jianyu Weng
, et al.
·
Blood
·
2
Efficacy and Safety Analysis of Venetoclax Combined with Azacitidine in Real-World Treatment of Patients with AML
2023
·
Xin Huang
, Chengxin Deng
, et al.
·
Blood
·
1
PDF
Show more works
View as search
Works count:
52
Citation count:
575
H-index:
9
I10-index:
9
Year
Topic
Type